Pay in 4 interest-free payments of $5.49 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
It is commonly examined in experimental settings focused on receptor-specific activity, peptide behavior, and analytical assay applications
That concentration of revenue reflects a combination of high per-unit pricing (typically USD 100,000-300,000 per patient per year for approved antibody therapeutics), reasonable duration of therapy in maintenance settings, and a steady supply of new approvals
it has not completed Phase 3 trials in any jurisdiction
the vial yields ~30 once-daily doses
US$ 21.02
US$ 23.12
US$ 23.93
US$ 29.29
US$ 22.35
US$ 26.60
US$ 20.42
US$ 25.19
US$ 22.23
US$ 29.93
US$ 23.55
